SLC3A2 and schizophrenia: From the perspective of the hypoglutamatergic hypothesis and experimental evidence, decreased mRNA expression levels of SLC7A11 and SLC3A2 in peripheral blood could be developed as accurate tools for diagnosing schizophrenia.